Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children

<h4>Background</h4> <p>The RTS,S/AS01 malaria vaccine candidate is being evaluated for implementation.</p> <h4>Methods</h4> <p>We conducted 7 years follow-up of children who were randomized at age 5 to 17 months to receive three doses of either the RTS,S/AS...

Podrobná bibliografie
Hlavní autoři:	Olotu, A, Fegan, G, Juliana, W, Nyangweso, G, Leach, A, Marc, L, Kaslow, D, Njuguna, P, Kevin, M, Bejon, P
Médium:	Journal article
Vydáno:	Massachusetts Medical Society 2016

Podobné jednotky

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
Autor: Olotu, A, a další
Vydáno: (2013)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
Autor: Olotu, A, a další
Vydáno: (2010)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
Autor: Bejon, P, a další
Vydáno: (2009)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
Autor: Olotu, A, a další
Vydáno: (2014)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children
Autor: Ndungu, F, a další
Vydáno: (2019)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.
Autor: Ally Olotu, a další
Vydáno: (2014-01-01)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
Autor: Bejon, P, a další
Vydáno: (2011)

RTS,S/AS01 malaria vaccine in African children.
Autor: Hill, A
Vydáno: (2012)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
Autor: Bejon, P, a další
Vydáno: (2008)

Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
Autor: Robert M. Mugo, a další
Vydáno: (2021-12-01)

Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
Autor: Mugo, RM, a další
Vydáno: (2021)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children [version 1; peer review: 1 approved, 2 approved with reservations]
Autor: Francis M. Ndungu, a další
Vydáno: (2019-03-01)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.
Autor: Lievens, M, a další
Vydáno: (2011)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children
Autor: Lievens Marc, a další
Vydáno: (2011-08-01)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
Autor: Ally Olotu, a další
Vydáno: (2011-01-01)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
Autor: Olotu, A, a další
Vydáno: (2011)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
Autor: Juliette Fortpied, a další
Vydáno: (2020-06-01)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
Autor: Agnandji, S, a další
Vydáno: (2012)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
Autor: Lusingu, J, a další
Vydáno: (2010)

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
Autor: Agnandji, S, a další
Vydáno: (2011)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
Autor: Mark E Polhemus, a další
Vydáno: (2009-07-01)

Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
Autor: Olotu, A, a další
Vydáno: (2012)

Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
Autor: Ally Olotu, a další
Vydáno: (2012-01-01)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
Autor: Bejon, P, a další
Vydáno: (2008)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
Autor: John Lusingu, a další
Vydáno: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
Autor: John Lusingu, a další
Vydáno: (2010-11-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
Autor: John Lusingu, a další
Vydáno: (2010-01-01)

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
Autor: Ndungu, F, a další
Vydáno: (2012)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.
Autor: Vekemans, J, a další
Vydáno: (2011)

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data
Autor: Bejon, P, a další
Vydáno: (2013)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care
Autor: Vekemans Johan, a další
Vydáno: (2011-08-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
Autor: John N Waitumbi, a další
Vydáno: (2009-11-01)

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study
Autor: Gemma Moncunill, a další
Vydáno: (2022-01-01)

Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
Autor: Agnandji, S, a další
Vydáno: (2014)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
Autor: Griffin J. Bell, a další
Vydáno: (2020-06-01)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
Autor: Gosling, R, a další
Vydáno: (2015)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
Autor: Roly Gosling, a další
Vydáno: (2016-04-01)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
Autor: Horowitz, A, a další
Vydáno: (2012)

Unlocking the potential of novel RTS, S/AS01, and R21/Matrix‐M™ malaria vaccines in African nations
Autor: Malik Olatunde Oduoye, a další
Vydáno: (2024-01-01)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
Autor: Warimwe, G, a další
Vydáno: (2013)